HyperScience Stock for Accredited Investors

AI / Machine Learning
By UpMarket Research  |  Last updated: September 2026
Founded 2014 HQ New York, US

Hyperscience is a private enterprise AI company that automates document processing and turns unstructured content into structured data. It offers a machine-learning-powered platform for office work automation and efficiency. In December 2021, HyperScience raised $100 million in its Series E at a $1.6 billion post-money valuation, led by Bessemer Venture Partners, Global Founders Capital, Stripes and Tiger Global Management (Hyperscience press release and SiliconANGLE).

Access to pre-IPO shares is available to accredited investors through UpMarket.

Last Reported Valuation
$1.6B
Series E, 12/22/21, Hyperscience press release and SiliconANGLE
UpMarket Estimate
$1.6B
Based on UpMarket valuation model

How to Invest in HyperScience Through UpMarket

HyperScience shares are not on public exchanges. UpMarket provides accredited investors access through secondary market transactions.

Step 01

Verify accredited investor status

Confirm eligibility under SEC Rule 501 of Regulation D. Income or net worth threshold applies.

Step 02

Create an UpMarket account

Complete KYC/AML onboarding. Typically 1–2 business days. Licensed rep assigned on signup.

Step 03

Review available HyperScience offerings

Full offering memoranda and risk disclosures provided before any commitment is required.

Step 04

Complete subscription documents

Review and sign subscription agreement. All documents handled digitally through the platform.

Step 05

Fund your investment

Wire transfer or ACH. $50K minimum. Funds held in custodial account until close.

Pre-IPO investments are illiquid, speculative, and involve risk of total loss of capital.

${{aum_amount_brokered_en}}B+
UpMarket has brokered over ${{aum_amount_brokered_en}} billion in alternative investments*
*Includes principal invested and appreciation of investments originated via the UpMarket platform based on historical trade volume and valuation estimates through {{aum_as_of_date_en}}. Of the total, approximately ${{aum_amount_managed_en}} million is managed by UpMarket Management, with the remaining originated investments managed by affiliates. Past performance is not predictive of future results.

Valuation Growth Over Time

Post-money valuation by round
Previous rounds Most recent
DateRoundAmount raisedValuation
Dec 2021 Series E $100M $1.6B

HyperScience's most recent reported round is its Series E, announced December 22, 2021. It raised $100 million at a reported post-money valuation of $1.6 billion, led by Bessemer Venture Partners, Global Founders Capital, Stripes and Tiger Global Management. Source: Hyperscience press release and SiliconANGLE. Data as of September 27, 2026.

HyperScience Revenue and Growth

Annual revenue

Why Investors Are Watching HyperScience

Growth Signal

Hyperscience raised $100M to expand automation platform

Hyperscience announced a $100 million funding round, signaling continued investor support for enterprise automation. The company said the capital will fund international expansion and further platform development.

Product Milestone

AI platform processes documents at massive scale automatically

Hyperscience describes its agentic AI platform as reading, understanding, and processing documents at massive scale. Its software is built to automate structured and semi-structured document workflows, including data entry and invoice extraction.

Market Opportunity

Enterprise document automation targets compliance-heavy workflows

Hyperscience positions its software for enterprise office work and compliance-driven data reconciliation. The product aims to streamline complex processes and increase productivity in document-heavy operations.

Interested in HyperScience stock? Fill out the form above or sign up directly. Subject to availability. Accredited investors only.

Request access →

HyperScience Leadership Team

Andrew Joiner
CEO
Steven Vineyard
CFO
Tony Lee
CTO

UpMarket Investment Curation Process

  • Full diligence on every offering

    UpMarket curates and conducts independent diligence on every investment opportunity before it reaches the platform.

  • Strategy, fees & legal reviewed in full

    We review every offering's strategy, risk management, liquidity, fees, valuation methodology, tax matters, and all third-party providers: legal counsel, auditor, administrator, and custodian.

  • Disciplined managers only

    We offer investments exclusively from disciplined managers that pursue unique strategies across an array of asset classes.

  • Built around your objectives

    Our goal is to empower you to build a portfolio that best meets your individual investment objectives.

Ready to access institutional-grade private market investments? Unlock private markets

HyperScience Stock FAQ

No. As of March 2026, HyperScience is a private company and does not trade on any public stock exchange. Accredited investors can access HyperScience shares through UpMarket, a FINRA-registered broker-dealer that specializes in pre-IPO investments.

HyperScience does not have a public stock price because it is privately held. The most recent known share price comes from its last funding round. Pre-IPO share prices on the secondary market may differ from the last round price depending on supply, demand, and market conditions.

Yes. Accredited investors can indicate interest in HyperScience shares through UpMarket by filling out the form on this page or creating an account at upmarket.co. All pre-IPO offerings are subject to availability and require a $50,000 minimum investment. UpMarket is a FINRA-registered broker-dealer and has brokered alternative investments since 2019.

Pre-IPO investments carry significant risks. HyperScience shares are illiquid, meaning there is no public market to sell them quickly. There is no guaranteed exit timeline or return. The investment is speculative in nature, and investors should be prepared for the possibility of total loss. Valuations of private companies can fluctuate substantially between funding rounds. Investors should consult their financial advisor and review all offering documents before investing.

In a pre-IPO transaction, accredited investors purchase shares from existing shareholders (such as employees, early investors, or other holders) through secondary market platforms. The company itself does not issue new shares in these transactions. UpMarket facilitates these trades as a FINRA-registered broker-dealer, handling compliance, documentation, and settlement on behalf of both parties.

There are two primary exit paths for pre-IPO holdings: selling your shares on the secondary market to another buyer, or holding until the company completes an IPO or is acquired. Both paths are subject to transfer restrictions, company approval (right of first refusal), and market conditions. The timing of any exit is unpredictable, and investors should plan for a multi-year holding period.

The minimum investment for most pre-IPO offerings on UpMarket is $50,000. This amount may vary depending on the specific offering and share availability. There are no fees to create an UpMarket account or browse available investments. Investors only pay transaction-related fees when they complete an investment.

UpMarket's valuation estimate is derived from a proprietary model that incorporates multiple data sources: funding round data (Caplight), revenue estimates (Sacra), secondary market pricing, and public company comparables. The model applies a private company discount to the public comp multiple to account for illiquidity and information asymmetry. This estimate is not investment advice and may differ substantially from the price at which shares actually trade.

HyperScience was valued at $1.6B in its December 2021 Series E. Accredited investors can request HyperScience access through UpMarket.

Invest in HyperScience Request access